본문 바로가기

추천 검색어

실시간 인기 검색어

학술논문

Outcomes of neoadjuvant chemoradiotherapy in T4 rectal cancer patients: a real-world single institution experience

이용수 0

영문명
발행기관
대한방사선종양학회
저자명
Reza Ghalehtaki Kasra Kolahdouzan Guglielmo Niccolò Piozzi Saeid Rezaei Zoha Shaka Nima Mousavi Darzikolaee Reyhaneh Bayani Behnam Behboudi Mahdi Aghili Felipe Couñago Azadeh Sharifian Farzaneh Bagheri Reza Nazari Naeim Nabian Mohammad Babaei Mohsen Ahmadi Tafti Mohammadsadegh Fazeli Farshid Farhan
간행물 정보
『대한방사선종양학회지』제42권 제4호, 273~280쪽, 전체 8쪽
주제분류
의약학 > 종양학
파일형태
PDF
발행일자
2024.12.31
4,000

구매일시로부터 72시간 이내에 다운로드 가능합니다.
이 학술논문 정보는 (주)교보문고와 각 발행기관 사이에 저작물 이용 계약이 체결된 것으로, 교보문고를 통해 제공되고 있습니다.

1:1 문의
논문 표지

국문 초록

Purpose: Treatment outcomes of locally advanced rectal cancer have improved significantly in recent decades. This retrospective study aimed to assess the efficacy of neoadjuvant chemoradiotherapy (nCRT) followed by surgery in patients with T4 rectal cancer and the different outcomes between T4a and T4b patients. Materials and Methods: A total of 60 clinically T4 rectal cancer patients who underwent nCRT were included in the analysis. Patient characteristics, treatment regimens, down-staging rates, pathological response, and overall survival (OS) were evaluated. Results: Both T4a and T4b patients experienced down-staging following nCRT (36.6% and 6.2% respectively; p = 0.021). T4a patients exhibited a higher rate of pathological complete response (pCR) than T4b patients (13.3% in T4a vs. 0% in T4b; p = 0.122). After a median follow-up of 36 months, the OS and recurrence-free survival (RFS) of T4a patients were significantly higher compared to T4b patients (hazard ratio [HR] = 2.52, 95% confidence interval [CI] 1.05-6.05, p = 0.038 for OS; HR = 2.32, 95% CI 1.09-4.92, p = 0.025 for RFS). Conclusion: This study provides valuable insights into the effectiveness of nCRT in T4 rectal cancer patients. Although down-staging was observed in both T4a and T4b subgroups, achieving a pCR remains a challenge, particularly in T4b patients. Further research is needed to optimize treatment strategies and enhance pCR rates in T4 rectal cancer patients to improve oncologic outcomes.

영문 초록

목차

Introduction
Materials and Methods
Results
Discussion and Conclusion
Statement of Ethics
Conflict of Interest
Funding
Author Contributions
Data Availability Statement
References

키워드

해당간행물 수록 논문

참고문헌

교보eBook 첫 방문을 환영 합니다!

신규가입 혜택 지급이 완료 되었습니다.

바로 사용 가능한 교보e캐시 1,000원 (유효기간 7일)
지금 바로 교보eBook의 다양한 콘텐츠를 이용해 보세요!

교보e캐시 1,000원
TOP
인용하기
APA

Reza Ghalehtaki,Kasra Kolahdouzan,Guglielmo Niccolò Piozzi,Saeid Rezaei,Zoha Shaka,Nima Mousavi Darzikolaee,Reyhaneh Bayani,Behnam Behboudi,Mahdi Aghili,Felipe Couñago,Azadeh Sharifian,Farzaneh Bagheri,Reza Nazari,Naeim Nabian,Mohammad Babaei,Mohsen Ahmadi Tafti,Mohammadsadegh Fazeli,Farshid Farhan. (2024).Outcomes of neoadjuvant chemoradiotherapy in T4 rectal cancer patients: a real-world single institution experience. 대한방사선종양학회지, 42 (4), 273-280

MLA

Reza Ghalehtaki,Kasra Kolahdouzan,Guglielmo Niccolò Piozzi,Saeid Rezaei,Zoha Shaka,Nima Mousavi Darzikolaee,Reyhaneh Bayani,Behnam Behboudi,Mahdi Aghili,Felipe Couñago,Azadeh Sharifian,Farzaneh Bagheri,Reza Nazari,Naeim Nabian,Mohammad Babaei,Mohsen Ahmadi Tafti,Mohammadsadegh Fazeli,Farshid Farhan. "Outcomes of neoadjuvant chemoradiotherapy in T4 rectal cancer patients: a real-world single institution experience." 대한방사선종양학회지, 42.4(2024): 273-280

결제완료
e캐시 원 결제 계속 하시겠습니까?
교보 e캐시 간편 결제